Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn if the Arabin pessary can reduce preterm birth less than 37 weeks 0 days in singleton pregnancies that have a short cervix.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gene Lee, MD
Collaborators
NCT02997345 · Fetal Membranes, Premature Rupture, Preterm Premature Rupture of the Membranes, and more
NCT06417385 · Premature Birth, Breastfeeding, Exclusive, and more
NCT05397197 · Premature Birth
NCT07306793 · Neonatal İntensive Care, Nutrition With A Chronobiological Approach, and more
NCT03819933 · Preterm Pregnancy, Premature Birth
University of Kansas Medical Center
Kansas City, Kansas
Medical University of South Carolina
Charleston, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions